FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder

Mov Disord. 2017 Oct;32(10):1482-1486. doi: 10.1002/mds.27094. Epub 2017 Jul 22.

Abstract

Background: Idiopathic REM sleep behavior disorder is a prodromal stage of Parkinson's disease and dementia with Lewy bodies. Hyposmia, reduced dopamine transporter binding, and expression of the brain metabolic PD-related pattern were each associated with increased risk of conversion to PD. The objective of this study was to study the relationship between the PD-related pattern, dopamine transporter binding, and olfaction in idiopathic REM sleep behavior disorder.

Methods: In this cross-sectional study, 21 idiopathic REM sleep behavior disorder subjects underwent 18 F-fluorodeoxyglucose PET, dopamine transporter imaging, and olfactory testing. For reference, we included 18 F-fluorodeoxyglucose PET data of 19 controls, 20 PD patients, and 22 patients with dementia with Lewy bodies. PD-related pattern expression z-scores were computed from all PET scans.

Results: PD-related pattern expression was higher in idiopathic REM sleep behavior disorder subjects compared with controls (P = 0.048), but lower compared with PD (P = 0.001) and dementia with Lewy bodies (P < 0.0001). PD-related pattern expression was higher in idiopathic REM sleep behavior disorder subjects with hyposmia and in subjects with an abnormal dopamine transporter scan (P < 0.05, uncorrected).

Conclusion: PD-related pattern expression, dopamine transporter binding, and olfaction may provide complementary information for predicting phenoconversion. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

Keywords: 18F-FDG-PET; Parkinson's disease-related pattern; dopamine transporter 123I-FP-CIT SPECT; idiopathic REM sleep behavior disorder; olfaction.

MeSH terms

  • Aged
  • Analysis of Variance
  • Cross-Sectional Studies
  • Dopamine Plasma Membrane Transport Proteins / metabolism*
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Lewy Body Disease / diagnostic imaging
  • Male
  • Middle Aged
  • Olfaction Disorders / diagnostic imaging
  • Olfaction Disorders / etiology*
  • Parkinson Disease / diagnostic imaging
  • Positron-Emission Tomography*
  • Psychiatric Status Rating Scales
  • REM Sleep Behavior Disorder* / complications
  • REM Sleep Behavior Disorder* / diagnostic imaging
  • REM Sleep Behavior Disorder* / metabolism
  • Tomography, Emission-Computed, Single-Photon*

Substances

  • Dopamine Plasma Membrane Transport Proteins
  • Fluorodeoxyglucose F18